NCT02355821COMPLETEDanonymous

Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Sponsor

Source record

National Research Center for Preventive Medicine

Phase

Source record

Modality

AI-normalized

small molecule

Target

AI-normalized

Moxonidine, Bisoprolol

Indication / condition

AI-normalized

Osteopenia

Intervention

Source record

Moxonidine, Bisoprolol

Related intelligence directories

Indication directory: Osteopenia Modality directory: small molecule Target directory: Moxonidine

Source & freshness

Source record

NCT ID

NCT02355821

Original source

ClinicalTrials.gov

Source last updated

Sep 01, 2021

Ingested at

Jun 19, 2026

Internal sync

Jun 19, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT02355821

Title

Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Sponsor

National Research Center for Preventive Medicine

Status

COMPLETED

Phase

Condition raw

Osteopenia, Arterial Hypertension

Condition normalized

Osteopenia, Arterial Hypertension

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Moxonidine, Bisoprolol

Target normalized

Moxonidine, Bisoprolol

Interventions

Moxonidine, Bisoprolol

Public preview

Source record

This study evaluates the effect of moxonidine versus bisoprolol on collagen type 1 C-telopeptide in postmenopausal female patients with arterial hypertension and osteopenia.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT02355821

Status

COMPLETED

Phase

Sponsor

National Research Center for Preventive Medicine

Executive brief

Investment-Ready Snapshot

This study evaluates the effect of moxonidine versus bisoprolol on collagen type 1 C-telopeptide in postmenopausal female patients with arterial hypertension and osteopenia.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedSep 01, 2021

Internal syncJun 19, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02355821

Indication

Osteopenia

Modality

small molecule

Target

Moxonidine, Bisoprolol

Intervention

Moxonidine, Bisoprolol

Source record